JP2007519619A5 - - Google Patents

Download PDF

Info

Publication number
JP2007519619A5
JP2007519619A5 JP2006542704A JP2006542704A JP2007519619A5 JP 2007519619 A5 JP2007519619 A5 JP 2007519619A5 JP 2006542704 A JP2006542704 A JP 2006542704A JP 2006542704 A JP2006542704 A JP 2006542704A JP 2007519619 A5 JP2007519619 A5 JP 2007519619A5
Authority
JP
Japan
Prior art keywords
inhibitor
group
phenyl
propyl
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006542704A
Other languages
English (en)
Japanese (ja)
Other versions
JP5107579B2 (ja
JP2007519619A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/040211 external-priority patent/WO2005055928A2/en
Publication of JP2007519619A publication Critical patent/JP2007519619A/ja
Publication of JP2007519619A5 publication Critical patent/JP2007519619A5/ja
Application granted granted Critical
Publication of JP5107579B2 publication Critical patent/JP5107579B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006542704A 2003-12-02 2004-12-01 新規の種類のヒストン脱アセチル化酵素阻害剤としてのZn2+キレートモチーフ係留短鎖脂肪酸 Expired - Fee Related JP5107579B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US52634803P 2003-12-02 2003-12-02
US60/526,348 2003-12-02
PCT/US2004/040211 WO2005055928A2 (en) 2003-12-02 2004-12-01 Zn2+ -chelating motif-tethered short -chain fatty acids as a novel class of histone deacetylase inhibitors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011144993A Division JP5702681B2 (ja) 2003-12-02 2011-06-29 新規の種類のヒストン脱アセチル化酵素阻害剤としてのZn2+キレートモチーフ係留短鎖脂肪酸

Publications (3)

Publication Number Publication Date
JP2007519619A JP2007519619A (ja) 2007-07-19
JP2007519619A5 true JP2007519619A5 (cg-RX-API-DMAC7.html) 2011-08-18
JP5107579B2 JP5107579B2 (ja) 2012-12-26

Family

ID=34676611

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006542704A Expired - Fee Related JP5107579B2 (ja) 2003-12-02 2004-12-01 新規の種類のヒストン脱アセチル化酵素阻害剤としてのZn2+キレートモチーフ係留短鎖脂肪酸
JP2011144993A Expired - Fee Related JP5702681B2 (ja) 2003-12-02 2011-06-29 新規の種類のヒストン脱アセチル化酵素阻害剤としてのZn2+キレートモチーフ係留短鎖脂肪酸

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011144993A Expired - Fee Related JP5702681B2 (ja) 2003-12-02 2011-06-29 新規の種類のヒストン脱アセチル化酵素阻害剤としてのZn2+キレートモチーフ係留短鎖脂肪酸

Country Status (9)

Country Link
US (2) US9115090B2 (cg-RX-API-DMAC7.html)
EP (1) EP1696898B1 (cg-RX-API-DMAC7.html)
JP (2) JP5107579B2 (cg-RX-API-DMAC7.html)
AU (1) AU2004296764B2 (cg-RX-API-DMAC7.html)
CA (1) CA2552279C (cg-RX-API-DMAC7.html)
DK (1) DK1696898T3 (cg-RX-API-DMAC7.html)
ES (1) ES2562778T3 (cg-RX-API-DMAC7.html)
HU (1) HUE028490T2 (cg-RX-API-DMAC7.html)
WO (1) WO2005055928A2 (cg-RX-API-DMAC7.html)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7154002B1 (en) 2002-10-08 2006-12-26 Takeda San Diego, Inc. Histone deacetylase inhibitors
US7250514B1 (en) 2002-10-21 2007-07-31 Takeda San Diego, Inc. Histone deacetylase inhibitors
US7375228B2 (en) 2003-03-17 2008-05-20 Takeda San Diego, Inc. Histone deacetylase inhibitors
CA2552279C (en) 2003-12-02 2014-07-15 The Ohio State University Research Foundation Zn2+-chelating motif-tethered short -chain fatty acids as a novel class of histone deacetylase inhibitors
JP2008505969A (ja) * 2004-07-12 2008-02-28 メルク エンド カムパニー インコーポレーテッド ヒストン脱アセチル化酵素の阻害剤
US7642275B2 (en) 2004-12-16 2010-01-05 Takeda San Diego, Inc. Histone deacetylase inhibitors
JP2008540574A (ja) 2005-05-11 2008-11-20 タケダ サン ディエゴ インコーポレイテッド ヒストンデアセチラーゼ阻害剤
CA2615105A1 (en) 2005-07-14 2007-01-25 Takeda San Diego, Inc. Histone deacetylase inhibitors
CN101374801B (zh) * 2005-12-19 2014-07-02 梅特希尔基因公司 用于增强抗真菌剂活性的组蛋白脱乙酰酶抑制剂
JP2010513326A (ja) * 2006-12-19 2010-04-30 メシルジーン インコーポレイテッド ヒストンデアセチラーゼの阻害薬及びそのプロドラッグ
US8796330B2 (en) 2006-12-19 2014-08-05 Methylgene Inc. Inhibitors of histone deacetylase and prodrugs thereof
CN101417967A (zh) * 2007-10-26 2009-04-29 浙江海正药业股份有限公司 组蛋白去乙酰酶抑制剂、其组合物及其应用
AU2009289649B2 (en) 2008-09-03 2016-05-05 Biomarin Pharmaceutical Inc. Compositions including 6-aminohexanoic acid derivatives as HDAC inhibitors
BRPI0922770A2 (pt) * 2008-12-01 2019-09-24 Procter & Gamble sistemas de perfume
GB0903480D0 (en) * 2009-02-27 2009-04-08 Chroma Therapeutics Ltd Enzyme Inhibitors
CA2763786C (en) * 2009-06-08 2014-09-30 Gilead Sciences, Inc. Alkanoylamino benzamide aniline hdac inihibitor compounds
WO2011103563A1 (en) * 2010-02-22 2011-08-25 Arno Therapeutics, Inc Methods and compositions for inhibiting and preventing the growth of malignant mast cells
WO2011106627A1 (en) * 2010-02-26 2011-09-01 Millennium Pharmaceuticals, Inc. Substituted hydroxamic acids and uses thereof
WO2011106632A1 (en) * 2010-02-26 2011-09-01 Millennium Pharmaceuticals, Inc. Substituted hydroxamic acids and uses thereof
WO2012112447A2 (en) * 2011-02-14 2012-08-23 Dana-Farber Cancer Institute, Inc. Histone deacetylase inhibitors and methods of use thereof
WO2012118782A1 (en) 2011-02-28 2012-09-07 Repligen Corporation Histone deacetylase inhibitors
US8957066B2 (en) 2011-02-28 2015-02-17 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
US10059723B2 (en) 2011-02-28 2018-08-28 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
WO2013041407A1 (en) * 2011-09-19 2013-03-28 Cellzome Ag Hydroxamic acids as hdac6 inhibitors
WO2013052110A1 (en) 2011-10-03 2013-04-11 The Trustees Of Columbia University In The City Of New York Novel molecules that selectively inhibit histone deacetylase 6 relative to histone deacetylase 1
US20140271604A1 (en) * 2013-03-12 2014-09-18 Stefan Proniuk HDAC Inhibitor Polymorphic Forms and Methods of Use
RU2665554C2 (ru) 2013-03-15 2018-08-31 Байомарин Фармасьютикал Инк. Ингибиторы hdac
MX368293B (es) 2013-11-20 2019-09-27 Ohio State Innovation Foundation Métodos para suprimir caquexia relacionada a cáncer.
CA2933907A1 (en) 2013-12-23 2015-07-02 The Trustees Of Columbia University In The City Of New York Selective hdac6 inhibitors
WO2016161268A1 (en) 2015-04-01 2016-10-06 Enanta Pharmaceuticals, Inc. Hepatitis b antviral agents
US10738035B2 (en) 2015-05-13 2020-08-11 Enanta Pharmaceuticals, Inc. Hepatitis B antiviral agents
EP3307746A1 (en) * 2015-05-18 2018-04-18 National and Kapodistrian Universty of Athens Autotaxin inhibitors and uses thereof
WO2017011552A1 (en) 2015-07-13 2017-01-19 Enanta Pharmaceuticals, Inc. Hepatitis b antiviral agents
US10301255B2 (en) 2015-07-22 2019-05-28 Enanta Pharmaceuticals, Inc. Hepatitis B antiviral agents
WO2017015451A1 (en) * 2015-07-22 2017-01-26 Enanta Pharmaceuticals, Inc. Hepatitis b antiviral agents
US10022342B2 (en) 2015-09-02 2018-07-17 Ohio State Innovation Foundation Methods and compositions for treating multiple myeloma
WO2017136403A1 (en) 2016-02-02 2017-08-10 Enanta Pharmaceuticals, Inc. Hepatitis b antiviral agents
KR102398439B1 (ko) 2016-03-07 2022-05-16 이난타 파마슈티칼스, 인코포레이티드 B형 간염 항바이러스제
EP3468561A4 (en) 2016-06-10 2019-12-04 Enanta Pharmaceuticals, Inc. Hepatitis b antiviral agents
WO2018223122A1 (en) * 2017-06-02 2018-12-06 Ohio State Innovation Foundation Hdac3-selective inhibitors
SG11202001685TA (en) 2017-08-28 2020-03-30 Enanta Pharm Inc Hepatitis b antiviral agents
WO2019113173A1 (en) 2017-12-06 2019-06-13 Enanta Pharmaceuticals, Inc. Hepatitis b antiviral agents
US10723733B2 (en) 2017-12-06 2020-07-28 Enanta Pharmaceuticals, Inc. Hepatitis B antiviral agents
WO2019130346A1 (en) * 2017-12-27 2019-07-04 K Syed Zameer Ahmed Novel phenolic compounds from nerium indicum with anti-breast cancer activity
US11058678B2 (en) 2018-01-22 2021-07-13 Enanta Pharmaceuticals, Inc. Substituted heterocycles as antiviral agents
US10729688B2 (en) 2018-03-29 2020-08-04 Enanta Pharmaceuticals, Inc. Hepatitis B antiviral agents
TW202024093A (zh) 2018-09-21 2020-07-01 美商安塔製藥公司 作為抗病毒劑之官能化雜環
EP3883570A4 (en) 2018-11-21 2022-07-13 Enanta Pharmaceuticals, Inc. FUNCTIONALIZED HETEROCYCLES AS ANTIVIRAL AGENTS
WO2020247444A1 (en) 2019-06-03 2020-12-10 Enanta Pharmaceuticals, Inc, Hepatitis b antiviral agents
US11472808B2 (en) 2019-06-04 2022-10-18 Enanta Pharmaceuticals, Inc. Substituted pyrrolo[1,2-c]pyrimidines as hepatitis B antiviral agents
WO2020247561A1 (en) 2019-06-04 2020-12-10 Enanta Pharmaceuticals, Inc, Hepatitis b antiviral agents
WO2021007488A1 (en) 2019-07-11 2021-01-14 Enanta Pharmaceuticals, Inc. Substituted heterocycles as antiviral agents
WO2021055425A2 (en) 2019-09-17 2021-03-25 Enanta Pharmaceuticals, Inc. Functionalized heterocycles as antiviral agents
US11802125B2 (en) 2020-03-16 2023-10-31 Enanta Pharmaceuticals, Inc. Functionalized heterocyclic compounds as antiviral agents
HRP20251279T1 (hr) 2020-04-30 2025-12-05 Great Novel Therapeutics Biotech & Medicals Corporation Inhibitori histon deacetilaze za imunomodulaciju u tumorskom mikrookruženju
CN112225737B (zh) * 2020-12-11 2021-04-09 北京鑫开元医药科技有限公司 具有hdac抑制活性的化合物、制备方法、组合物及用途
CN112516142B (zh) * 2020-12-11 2021-10-15 北京华氏精恒医药科技有限公司 一种具有hdac抑制活性的药物组合物、制备方法及其用途
CN114539098B (zh) * 2022-02-26 2024-05-24 青岛大学 一种双功能hdac6抑制剂、合成方法及应用

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5668650A (en) * 1979-11-07 1981-06-09 Otsuka Pharmaceut Co Ltd Benzoic acid amide derivative
DE3607993A1 (de) 1986-03-11 1987-09-17 Basf Ag Verfahren zur herstellung von diaziridinen und produkte daraus
NZ219974A (en) 1986-04-22 1989-08-29 Goedecke Ag N-(2'-aminophenyl)-benzamide derivatives, process for their preparation and their use in the control of neoplastic diseases
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
US5369108A (en) * 1991-10-04 1994-11-29 Sloan-Kettering Institute For Cancer Research Potent inducers of terminal differentiation and methods of use thereof
ATE198601T1 (de) 1992-05-20 2001-01-15 Merck & Co Inc Ester derivate von 4-aza-steroiden
WO1993023040A1 (en) 1992-05-20 1993-11-25 Merck & Co., Inc. 17-ethers and thioethers of 4-aza-steroids
US5783593A (en) 1993-11-04 1998-07-21 Abbott Laboratories Inhibitors of squalene synthetase and protein farnesyltransferase
US5958957A (en) 1996-04-19 1999-09-28 Novo Nordisk A/S Modulators of molecules with phosphotyrosine recognition units
IT1283637B1 (it) * 1996-05-14 1998-04-23 Italfarmaco Spa Composti ad attivita' antinfiammatoria ed immunosoppressiva
JP3354090B2 (ja) * 1996-09-30 2002-12-09 シエーリング アクチエンゲゼルシャフト 分化誘導剤
US6174905B1 (en) 1996-09-30 2001-01-16 Mitsui Chemicals, Inc. Cell differentiation inducer
US5776888A (en) 1997-02-07 1998-07-07 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US6045829A (en) 1997-02-13 2000-04-04 Elan Pharma International Limited Nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers
US6034584A (en) * 1997-08-06 2000-03-07 Allen-Bradley Company, Llc Arrangement for mechanically coupling an overload relay to a contactor
JP4405602B2 (ja) 1998-04-16 2010-01-27 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト ヒストン脱アセチル化酵素阻害剤
WO1999065867A1 (en) 1998-06-17 1999-12-23 Du Pont Pharmaceuticals Company Cyclic hydroxamic acids as metalloproteinase inhibitors
US6320078B1 (en) 1998-07-24 2001-11-20 Mitsui Chemicals, Inc. Method of producing benzamide derivatives
US7658938B2 (en) * 1999-02-22 2010-02-09 Merrion Reasearch III Limited Solid oral dosage form containing an enhancer
JP2001081031A (ja) 1999-08-30 2001-03-27 Schering Ag 溶解性および経口吸収性を改善したベンズアミド誘導体含有製剤
IL149363A0 (en) * 1999-11-10 2002-11-10 Warner Lambert Co Combination chemotherapy
KR20100035666A (ko) 1999-11-23 2010-04-05 메틸진 인크. 히스톤 디아세틸라제의 억제제
IL151552A0 (en) 2000-03-17 2003-04-10 Bristol Myers Squibb Pharma Co Cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
JP2003528074A (ja) 2000-03-24 2003-09-24 メチルジーン インコーポレイテッド ヒストン脱アセチル化酵素の阻害剤
PE20020354A1 (es) * 2000-09-01 2002-06-12 Novartis Ag Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda)
CA2423868C (en) * 2000-09-29 2011-06-07 Prolifix Limited Carbamic acid compounds comprising an amide linkage as hdac inhibitors
US20020172967A1 (en) * 2001-02-13 2002-11-21 Gadek Thomas R. Identification of non-covalent complexes by mass spectrometry
WO2002074298A1 (en) * 2001-03-21 2002-09-26 Ono Pharmaceutical Co., Ltd. Il-6 production inhibitors
ITMI20011733A1 (it) 2001-08-07 2003-02-07 Italfarmaco Spa Derivati dell'acido idrossamico inibitori degli enzimi istone deacetilasi, quali nuovi farmaci antiinfiammatori inibenti la sintesi di citoc
JP3681673B2 (ja) 2001-10-31 2005-08-10 Jfe炉材株式会社 高炉樋用不定形耐火物
JP2003137866A (ja) * 2001-11-01 2003-05-14 Sankyo Co Ltd フェニレンジアミン誘導体
AU2003211362A1 (en) 2002-02-21 2003-09-09 Osaka Industrial Promotion Organization N-hydroxycarboxamide derivative
AU2003276824B8 (en) 2002-03-15 2009-01-22 The Regents Of The University Of Michigan Novel 2-amino-9-[(2-hydroxymethyl) cyclopropylidenemethyl] purines as antiviral agents
US20030225054A1 (en) 2002-06-03 2003-12-04 Jingwu Duan Combined use of tace inhibitors and COX2 inhibitors as anti-inflammatory agents
TW200426138A (en) 2002-12-10 2004-12-01 Hoffmann La Roche Novel arylene-carboxylic acid (2-amino-phenyl)-amide derivatives, their manufacture and use as pharmaceutical agents
ITMI20030025A1 (it) 2003-01-10 2004-07-11 Italfarmaco Spa Derivati dell'acido idrossammico ad attivita' antinfiammatoria.
KR20060015534A (ko) * 2003-04-25 2006-02-17 더 펜 스테이트 리서치 파운데이션 성장 억제, 지질 유래된 생활성 화합물의 전신 전달을 위한방법 및 시스템
EP1660437B1 (en) * 2003-08-26 2008-10-15 Amorepacific Corporation Hydroxamic acid derivatives and the method for preparing thereof
JP4939941B2 (ja) * 2003-08-26 2012-05-30 株式會社アモーレパシフィック ヒドロキサム酸誘導体及びその製造方法
CA2552279C (en) 2003-12-02 2014-07-15 The Ohio State University Research Foundation Zn2+-chelating motif-tethered short -chain fatty acids as a novel class of histone deacetylase inhibitors
BRPI0515012A (pt) 2004-08-13 2008-07-01 Genentech Inc substáncia quìmica, composição e formulação farmacêutica, método de tratamento, método de inibição de pelo menos uma enzima que utiliza atp e uso

Similar Documents

Publication Publication Date Title
KR920021578A (ko) 포스프노/비아릴 치환된 디펩티드 유도체
US6927228B2 (en) Biaromatic compound activators of PPARγ-type receptors
ES2358426T3 (es) Compuestos para la inflamación y usos inmunorrelacionados.
KR910016765A (ko) 아세트산 유도체
RU2437877C2 (ru) Новые производные тиофена в качестве агонистов рецептора s1p1/edg1
RU97103207A (ru) Арилтиосоединения в качестве антибактериальных и противовирусных средств
CA2458035A1 (en) Quaternary ammonium salts of omega-aminoalkylamides of r-2-aryl-propionic acids and pharmaceutical compositions containing them
AR048306A1 (es) Derivados de acidos carboxilicos aromaticos con capacidad moduladora de los niveles de insulina, composiciones farmaceuticas que los contienen y su uso en el tratamiento de trastornos metabolicos que responden a la regulacion de gpr40
RU2403247C2 (ru) Модуляторы никотиновых ацетилхолиновых рецепторов альфа 7 и их терапевтические применения
FR2861076B1 (fr) Derives de n-heterocyclymethylbenzamide, leur preparation et leur application en therapeutique
RU2011110435A (ru) Пролекарства метилгидрофумарата, фармацетические композиции с ними и способы применения
KR910004543A (ko) Acat 억제제
RU2008106058A (ru) Производные пиридазинона в качестве агонистов рецептора тиреоидного гормона
RU2012129737A (ru) Замещенные бензамидные производные
CA2392570A1 (en) 4-pyrimidinyl-n-acyl-l-phenylalanines
US20070105913A1 (en) Alkynyl aryl carboxamides
JP2004533450A5 (cg-RX-API-DMAC7.html)
RU2383542C2 (ru) Замещенные гидантоины
RU99122343A (ru) Производные 2-(иминометил)аминофенила, способ их получения, их применение в качестве лекарственных средств и фармацевтические композиции на их основе
JP2005533013A5 (cg-RX-API-DMAC7.html)
US7951806B2 (en) Plasminogen activator inhibitor-1 inhibitor
JP2005522492A5 (cg-RX-API-DMAC7.html)
JP2003506438A (ja) 抗菌剤
JP2006512321A5 (cg-RX-API-DMAC7.html)
JP2002526530A5 (cg-RX-API-DMAC7.html)